ID   SYYC_HUMAN              Reviewed;         528 AA.
AC   P54577; B3KWK4; D3DPQ4; O43276; Q53EN1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   15-MAR-2017, entry version 183.
DE   RecName: Full=Tyrosine--tRNA ligase, cytoplasmic;
DE            EC=6.1.1.1;
DE   AltName: Full=Tyrosyl-tRNA synthetase;
DE            Short=TyrRS;
DE   Contains:
DE     RecName: Full=Tyrosine--tRNA ligase, cytoplasmic, N-terminally processed;
GN   Name=YARS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8552597; DOI=10.1073/pnas.93.1.166;
RA   Ribas de Pouplana L., Frugier M., Quinn C.L., Schimmel P.;
RT   "Evidence that two present-day components needed for the genetic code
RT   appeared after nucleated cells separated from eubacteria.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:166-170(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9162081; DOI=10.1074/jbc.272.22.14420;
RA   Kleeman T.A., Wei D., Simpson K.L., First E.A.;
RT   "Human tyrosyl-tRNA synthetase shares amino acid sequence homology
RT   with a putative cytokine.";
RL   J. Biol. Chem. 272:14420-14425(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Bone, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-16.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-16, ACETYLATION AT GLY-2, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (OCT-2004) to UniProtKB.
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND GLY-2, CLEAVAGE OF
RP   INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-197; LYS-206; LYS-474;
RP   LYS-482 AND LYS-490, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-205 AND SER-386, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.18 ANGSTROMS) OF 1-342, AND SUBUNIT.
RX   PubMed=12427973; DOI=10.1073/pnas.242611799;
RA   Yang X.-L., Skene R.J., McRee D.E., Schimmel P.;
RT   "Crystal structure of a human aminoacyl-tRNA synthetase cytokine.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:15369-15374(2002).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 1-364 IN COMPLEX WITH
RP   TYROSINE.
RX   PubMed=14671330; DOI=10.1073/pnas.2136794100;
RA   Yang X.-L., Otero F.J., Skene R.J., McRee D.E., Schimmel P.,
RA   Ribas de Pouplana L.;
RT   "Crystal structures that suggest late development of genetic code
RT   components for differentiating aromatic side chains.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:15376-15380(2003).
RN   [17]
RP   SUBCELLULAR LOCATION, VARIANTS CMTDIC 153-VAL--VAL-156 DEL; ARG-41 AND
RP   LYS-196, AND CHARACTERIZATION OF VARIANTS CMTDIC ARG-41 AND LYS-196.
RX   PubMed=16429158; DOI=10.1038/ng1727;
RA   Jordanova A., Irobi J., Thomas F.P., Van Dijck P., Meerschaert K.,
RA   Dewil M., Dierick I., Jacobs A., De Vriendt E., Guergueltcheva V.,
RA   Rao C.V., Tournev I., Gondim F.A.A., D'Hooghe M., Van Gerwen V.,
RA   Callaerts P., Van Den Bosch L., Timmermans J.-P., Robberecht W.,
RA   Gettemans J., Thevelein J.M., De Jonghe P., Kremensky I.,
RA   Timmerman V.;
RT   "Disrupted function and axonal distribution of mutant tyrosyl-tRNA
RT   synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy.";
RL   Nat. Genet. 38:197-202(2006).
RN   [18]
RP   VARIANT LYS-274.
RX   PubMed=24627108; DOI=10.1007/s00415-014-7289-8;
RA   Schabhuettl M., Wieland T., Senderek J., Baets J., Timmerman V.,
RA   De Jonghe P., Reilly M.M., Stieglbauer K., Laich E., Windhager R.,
RA   Erwa W., Trajanoski S., Strom T.M., Auer-Grumbach M.;
RT   "Whole-exome sequencing in patients with inherited neuropathies:
RT   outcome and challenges.";
RL   J. Neurol. 261:970-982(2014).
CC   -!- FUNCTION: Catalyzes the attachment of tyrosine to tRNA(Tyr) in a
CC       two-step reaction: tyrosine is first activated by ATP to form Tyr-
CC       AMP and then transferred to the acceptor end of tRNA(Tyr).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: ATP + L-tyrosine + tRNA(Tyr) = AMP +
CC       diphosphate + L-tyrosyl-tRNA(Tyr).
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:12427973,
CC       ECO:0000269|PubMed:14671330}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16429158}.
CC   -!- DISEASE: Charcot-Marie-Tooth disease, dominant, intermediate type,
CC       C (CMTDIC) [MIM:608323]: A form of Charcot-Marie-Tooth disease, a
CC       disorder of the peripheral nervous system, characterized by
CC       progressive weakness and atrophy, initially of the peroneal
CC       muscles and later of the distal muscles of the arms. The dominant
CC       intermediate type C is characterized by clinical and pathologic
CC       features intermediate between demyelinating and axonal peripheral
CC       neuropathies, and motor median nerve conduction velocities ranging
CC       from 25 to 45 m/sec. {ECO:0000269|PubMed:16429158}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB39406.1; Type=Frameshift; Positions=354; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U40714; AAB39406.1; ALT_FRAME; mRNA.
DR   EMBL; U89436; AAB88409.1; -; mRNA.
DR   EMBL; AK125213; BAG54166.1; -; mRNA.
DR   EMBL; AK223608; BAD97328.1; -; mRNA.
DR   EMBL; CH471059; EAX07506.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07507.1; -; Genomic_DNA.
DR   EMBL; BC001933; AAH01933.1; -; mRNA.
DR   EMBL; BC004151; AAH04151.1; -; mRNA.
DR   EMBL; BC016689; AAH16689.1; -; mRNA.
DR   CCDS; CCDS368.1; -.
DR   RefSeq; NP_003671.1; NM_003680.3.
DR   UniGene; Hs.213264; -.
DR   PDB; 1N3L; X-ray; 1.18 A; A=1-364.
DR   PDB; 1NTG; X-ray; 2.21 A; A/B/C/D=359-528.
DR   PDB; 1Q11; X-ray; 1.60 A; A=1-364.
DR   PDB; 4Q93; X-ray; 2.10 A; A=1-364.
DR   PDB; 4QBT; X-ray; 2.10 A; A=1-364.
DR   PDBsum; 1N3L; -.
DR   PDBsum; 1NTG; -.
DR   PDBsum; 1Q11; -.
DR   PDBsum; 4Q93; -.
DR   PDBsum; 4QBT; -.
DR   ProteinModelPortal; P54577; -.
DR   SMR; P54577; -.
DR   BioGrid; 114134; 53.
DR   DIP; DIP-50415N; -.
DR   IntAct; P54577; 16.
DR   STRING; 9606.ENSP00000362576; -.
DR   BindingDB; P54577; -.
DR   ChEMBL; CHEMBL3179; -.
DR   DrugBank; DB01766; Beta-(2-Naphthyl)-Alanine.
DR   DrugBank; DB00135; L-Tyrosine.
DR   DrugBank; DB07205; N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE.
DR   DrugBank; DB08371; PARA-(BENZOYL)-PHENYLALANINE.
DR   DrugBank; DB03978; Tyrosinal.
DR   iPTMnet; P54577; -.
DR   PhosphoSitePlus; P54577; -.
DR   SwissPalm; P54577; -.
DR   BioMuta; YARS; -.
DR   DMDM; 13638438; -.
DR   REPRODUCTION-2DPAGE; IPI00007074; -.
DR   EPD; P54577; -.
DR   MaxQB; P54577; -.
DR   PaxDb; P54577; -.
DR   PeptideAtlas; P54577; -.
DR   PRIDE; P54577; -.
DR   DNASU; 8565; -.
DR   Ensembl; ENST00000373477; ENSP00000362576; ENSG00000134684.
DR   GeneID; 8565; -.
DR   KEGG; hsa:8565; -.
DR   UCSC; uc001bvy.2; human.
DR   CTD; 8565; -.
DR   DisGeNET; 8565; -.
DR   GeneCards; YARS; -.
DR   HGNC; HGNC:12840; YARS.
DR   HPA; HPA017936; -.
DR   HPA; HPA018950; -.
DR   HPA; HPA018954; -.
DR   MalaCards; YARS; -.
DR   MIM; 603623; gene.
DR   MIM; 608323; phenotype.
DR   neXtProt; NX_P54577; -.
DR   OpenTargets; ENSG00000134684; -.
DR   Orphanet; 100045; Autosomal dominant intermediate Charcot-Marie-Tooth disease type C.
DR   PharmGKB; PA37431; -.
DR   eggNOG; KOG2144; Eukaryota.
DR   eggNOG; KOG2241; Eukaryota.
DR   eggNOG; COG0073; LUCA.
DR   eggNOG; COG0162; LUCA.
DR   GeneTree; ENSGT00790000123100; -.
DR   HOGENOM; HOG000228237; -.
DR   HOVERGEN; HBG080113; -.
DR   InParanoid; P54577; -.
DR   KO; K01866; -.
DR   OMA; PIRKKFE; -.
DR   OrthoDB; EOG091G03XO; -.
DR   PhylomeDB; P54577; -.
DR   TreeFam; TF300898; -.
DR   BRENDA; 6.1.1.1; 2681.
DR   Reactome; R-HSA-379716; Cytosolic tRNA aminoacylation.
DR   ChiTaRS; YARS; human.
DR   EvolutionaryTrace; P54577; -.
DR   GeneWiki; YARS; -.
DR   GenomeRNAi; 8565; -.
DR   PMAP-CutDB; P54577; -.
DR   PRO; PR:P54577; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000134684; -.
DR   CleanEx; HS_YARS; -.
DR   ExpressionAtlas; P54577; baseline and differential.
DR   Genevisible; P54577; HS.
DR   GO; GO:0017101; C:aminoacyl-tRNA synthetase multienzyme complex; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005615; C:extracellular space; TAS:ProtInc.
DR   GO; GO:0017102; C:methionyl glutamyl tRNA synthetase complex; IBA:GO_Central.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005153; F:interleukin-8 receptor binding; TAS:ProtInc.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0004871; F:signal transducer activity; NAS:ProtInc.
DR   GO; GO:0000049; F:tRNA binding; IBA:GO_Central.
DR   GO; GO:0004831; F:tyrosine-tRNA ligase activity; TAS:Reactome.
DR   GO; GO:0006915; P:apoptotic process; TAS:ProtInc.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; IBA:GO_Central.
DR   GO; GO:0006437; P:tyrosyl-tRNA aminoacylation; TAS:ProtInc.
DR   CDD; cd00805; TyrRS_core; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   InterPro; IPR002305; aa-tRNA-synth_Ic.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR002547; tRNA-bd_dom.
DR   InterPro; IPR002307; Tyr-tRNA-ligase.
DR   Pfam; PF00579; tRNA-synt_1b; 1.
DR   Pfam; PF01588; tRNA_bind; 1.
DR   PRINTS; PR01040; TRNASYNTHTYR.
DR   SUPFAM; SSF50249; SSF50249; 1.
DR   TIGRFAMs; TIGR00234; tyrS; 1.
DR   PROSITE; PS50886; TRBD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Aminoacyl-tRNA synthetase; ATP-binding;
KW   Charcot-Marie-Tooth disease; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; Ligase;
KW   Neurodegeneration; Neuropathy; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Protein biosynthesis; Reference proteome; RNA-binding;
KW   tRNA-binding.
FT   CHAIN         1    528       Tyrosine--tRNA ligase, cytoplasmic.
FT                                /FTId=PRO_0000423285.
FT   INIT_MET      1      1       Removed; alternate.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|Ref.8}.
FT   CHAIN         2    528       Tyrosine--tRNA ligase, cytoplasmic, N-
FT                                terminally processed.
FT                                /FTId=PRO_0000055673.
FT   DOMAIN      364    468       tRNA-binding. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00209}.
FT   MOTIF        44     52       "HIGH" region.
FT   MOTIF       222    226       "KMSKS" region.
FT   BINDING      39     39       Tyrosine. {ECO:0000269|PubMed:14671330}.
FT   BINDING     166    166       Tyrosine. {ECO:0000269|PubMed:14671330}.
FT   BINDING     170    170       Tyrosine. {ECO:0000269|PubMed:14671330}.
FT   BINDING     173    173       Tyrosine. {ECO:0000269|PubMed:14671330}.
FT   BINDING     188    188       Tyrosine. {ECO:0000269|PubMed:14671330}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES       2      2       N-acetylglycine; in Tyrosine--tRNA
FT                                ligase, cytoplasmic, N-terminally
FT                                processed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|Ref.8}.
FT   MOD_RES     197    197       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     205    205       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     206    206       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     386    386       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     474    474       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     482    482       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     490    490       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VARIANT      41     41       G -> R (in CMTDIC; partial loss of
FT                                activity; dbSNP:rs121908833).
FT                                {ECO:0000269|PubMed:16429158}.
FT                                /FTId=VAR_026681.
FT   VARIANT     153    156       Missing (in CMTDIC).
FT                                {ECO:0000269|PubMed:16429158}.
FT                                /FTId=VAR_026682.
FT   VARIANT     170    170       Q -> H (in dbSNP:rs2128600).
FT                                /FTId=VAR_026683.
FT   VARIANT     196    196       E -> K (in CMTDIC; partial loss of
FT                                activity; dbSNP:rs121908834).
FT                                {ECO:0000269|PubMed:16429158}.
FT                                /FTId=VAR_026684.
FT   VARIANT     274    274       E -> K (found in a patient with
FT                                hereditary motor and sensory neuropathy;
FT                                unknown pathological significance;
FT                                dbSNP:rs758897498).
FT                                {ECO:0000269|PubMed:24627108}.
FT                                /FTId=VAR_073292.
FT   CONFLICT    143    143       H -> R (in Ref. 4; BAD97328).
FT                                {ECO:0000305}.
FT   HELIX         7     15       {ECO:0000244|PDB:1N3L}.
FT   STRAND       19     22       {ECO:0000244|PDB:1N3L}.
FT   HELIX        24     31       {ECO:0000244|PDB:1N3L}.
FT   STRAND       37     42       {ECO:0000244|PDB:1N3L}.
FT   HELIX        50     52       {ECO:0000244|PDB:1N3L}.
FT   HELIX        53     64       {ECO:0000244|PDB:1N3L}.
FT   STRAND       68     73       {ECO:0000244|PDB:1N3L}.
FT   HELIX        75     80       {ECO:0000244|PDB:1N3L}.
FT   TURN         81     84       {ECO:0000244|PDB:1N3L}.
FT   HELIX        87    108       {ECO:0000244|PDB:1N3L}.
FT   STRAND      115    119       {ECO:0000244|PDB:1N3L}.
FT   HELIX       120    122       {ECO:0000244|PDB:1N3L}.
FT   TURN        123    125       {ECO:0000244|PDB:1N3L}.
FT   HELIX       127    137       {ECO:0000244|PDB:1N3L}.
FT   HELIX       142    148       {ECO:0000244|PDB:1N3L}.
FT   TURN        149    152       {ECO:0000244|PDB:1N3L}.
FT   HELIX       161    176       {ECO:0000244|PDB:1N3L}.
FT   STRAND      180    185       {ECO:0000244|PDB:1N3L}.
FT   HELIX       186    188       {ECO:0000244|PDB:1N3L}.
FT   HELIX       189    198       {ECO:0000244|PDB:1N3L}.
FT   HELIX       199    202       {ECO:0000244|PDB:1N3L}.
FT   STRAND      208    212       {ECO:0000244|PDB:1N3L}.
FT   HELIX       238    246       {ECO:0000244|PDB:1N3L}.
FT   STRAND      247    249       {ECO:0000244|PDB:1Q11}.
FT   HELIX       259    266       {ECO:0000244|PDB:1N3L}.
FT   TURN        267    273       {ECO:0000244|PDB:1N3L}.
FT   STRAND      275    277       {ECO:0000244|PDB:1N3L}.
FT   HELIX       281    283       {ECO:0000244|PDB:1N3L}.
FT   STRAND      287    291       {ECO:0000244|PDB:1N3L}.
FT   HELIX       292    300       {ECO:0000244|PDB:1N3L}.
FT   HELIX       306    327       {ECO:0000244|PDB:1N3L}.
FT   HELIX       331    340       {ECO:0000244|PDB:1N3L}.
FT   HELIX       365    367       {ECO:0000244|PDB:1NTG}.
FT   STRAND      370    380       {ECO:0000244|PDB:1NTG}.
FT   STRAND      388    393       {ECO:0000244|PDB:1NTG}.
FT   STRAND      395    398       {ECO:0000244|PDB:1NTG}.
FT   STRAND      400    405       {ECO:0000244|PDB:1NTG}.
FT   TURN        407    409       {ECO:0000244|PDB:1NTG}.
FT   HELIX       412    414       {ECO:0000244|PDB:1NTG}.
FT   TURN        415    417       {ECO:0000244|PDB:1NTG}.
FT   STRAND      419    423       {ECO:0000244|PDB:1NTG}.
FT   STRAND      429    431       {ECO:0000244|PDB:1NTG}.
FT   STRAND      434    436       {ECO:0000244|PDB:1NTG}.
FT   STRAND      442    454       {ECO:0000244|PDB:1NTG}.
FT   STRAND      466    469       {ECO:0000244|PDB:1NTG}.
FT   STRAND      479    481       {ECO:0000244|PDB:1NTG}.
FT   HELIX       483    485       {ECO:0000244|PDB:1NTG}.
FT   HELIX       487    492       {ECO:0000244|PDB:1NTG}.
FT   STRAND      495    497       {ECO:0000244|PDB:1NTG}.
FT   STRAND      501    505       {ECO:0000244|PDB:1NTG}.
FT   STRAND      508    512       {ECO:0000244|PDB:1NTG}.
FT   STRAND      526    528       {ECO:0000244|PDB:1NTG}.
SQ   SEQUENCE   528 AA;  59143 MW;  00C7E88843905780 CRC64;
     MGDAPSPEEK LHLITRNLQE VLGEEKLKEI LKERELKIYW GTATTGKPHV AYFVPMSKIA
     DFLKAGCEVT ILFADLHAYL DNMKAPWELL ELRVSYYENV IKAMLESIGV PLEKLKFIKG
     TDYQLSKEYT LDVYRLSSVV TQHDSKKAGA EVVKQVEHPL LSGLLYPGLQ ALDEEYLKVD
     AQFGGIDQRK IFTFAEKYLP ALGYSKRVHL MNPMVPGLTG SKMSSSEEES KIDLLDRKED
     VKKKLKKAFC EPGNVENNGV LSFIKHVLFP LKSEFVILRD EKWGGNKTYT AYVDLEKDFA
     AEVVHPGDLK NSVEVALNKL LDPIREKFNT PALKKLASAA YPDPSKQKPM AKGPAKNSEP
     EEVIPSRLDI RVGKIITVEK HPDADSLYVE KIDVGEAEPR TVVSGLVQFV PKEELQDRLV
     VVLCNLKPQK MRGVESQGML LCASIEGINR QVEPLDPPAG SAPGEHVFVK GYEKGQPDEE
     LKPKKKVFEK LQADFKISEE CIAQWKQTNF MTKLGSISCK SLKGGNIS
//
